Trial intelligence / Profile preview

Anakinra for Cardiac Sarcoidosis

NCT04017936Phase 2Completed

Sponsor
Virginia Commonwealth University
Start
Oct 2020
Primary completion
Jun 2024
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in cardiac sarcoidosis (CS), sponsored by Virginia Commonwealth University. Started Oct 2020; status: completed.

02

Drugs

anakinra
03

Conditions

cardiac sarcoidosis (CS)

Beyond the preview

Go deeper on NCT04017936.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04017936.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call